Coinfections increase the risk of HIV acquisition, AIDS progression, and therapy and prophylaxis failure: a review

Few people exposed to human immunodeficiency virus (HIV) become infected. Among those infected, the rate of progression to full-blown acquired immunodeficiency syndrome (AIDS) and susceptibility to various opportunistic infections varies widely as does their response to antiretroviral the...

Full description

Saved in:
Bibliographic Details
Main Author: Robert Root-Bernstein
Format: Article
Language:English
Published: Academia.edu Journals 2024-08-01
Series:Academia Medicine
Online Access:https://www.academia.edu/122717237/Coinfections_increase_the_risk_of_HIV_acquisition_AIDS_progression_and_therapy_and_prophylaxis_failure_a_review
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823859728987455488
author Robert Root-Bernstein
author_facet Robert Root-Bernstein
author_sort Robert Root-Bernstein
collection DOAJ
description Few people exposed to human immunodeficiency virus (HIV) become infected. Among those infected, the rate of progression to full-blown acquired immunodeficiency syndrome (AIDS) and susceptibility to various opportunistic infections varies widely as does their response to antiretroviral therapies (ARTs). This review addresses these conundrums in light of Pasteur’s principle that “the terrain is as important as the germ”. Recent studies have demonstrated that the risk of acquiring an HIV infection, the rate at which AIDS progresses, and the degree to which individual patients respond to retroviral therapies are largely determined by the degrees of immunosuppression and inflammation preexisting at the time of HIV exposure. The primary drivers of preexisting immunosuppression and inflammation are non-HIV infections and possibly alloantigen and drug exposures. The immunologic insults stimulate increased C–C chemokine receptor type 5 co-expression with a cluster of differentiation 4 on monocytes and T cells, which is required for HIV infection and replication. Repeated predispository infections also degrade immune competence independent of HIV and undermine ART and pre-exposure prophylaxis effectiveness. Thus, non-HIV infections are as important to understanding susceptibility to HIV infection, its progression, and the effectiveness of treatments and prevention. Addressing these non-HIV predispository infections may provide novel preventative, diagnostic, and therapeutic opportunities.
format Article
id doaj-art-f4cd0b2322834545a48ba312c4af19cd
institution Kabale University
issn 2994-435X
language English
publishDate 2024-08-01
publisher Academia.edu Journals
record_format Article
series Academia Medicine
spelling doaj-art-f4cd0b2322834545a48ba312c4af19cd2025-02-10T22:28:19ZengAcademia.edu JournalsAcademia Medicine2994-435X2024-08-011310.20935/AcadMed7295Coinfections increase the risk of HIV acquisition, AIDS progression, and therapy and prophylaxis failure: a reviewRobert Root-Bernstein0Department of Physiology, Michigan State University, East Lansing, MI 48824, United States. Few people exposed to human immunodeficiency virus (HIV) become infected. Among those infected, the rate of progression to full-blown acquired immunodeficiency syndrome (AIDS) and susceptibility to various opportunistic infections varies widely as does their response to antiretroviral therapies (ARTs). This review addresses these conundrums in light of Pasteur’s principle that “the terrain is as important as the germ”. Recent studies have demonstrated that the risk of acquiring an HIV infection, the rate at which AIDS progresses, and the degree to which individual patients respond to retroviral therapies are largely determined by the degrees of immunosuppression and inflammation preexisting at the time of HIV exposure. The primary drivers of preexisting immunosuppression and inflammation are non-HIV infections and possibly alloantigen and drug exposures. The immunologic insults stimulate increased C–C chemokine receptor type 5 co-expression with a cluster of differentiation 4 on monocytes and T cells, which is required for HIV infection and replication. Repeated predispository infections also degrade immune competence independent of HIV and undermine ART and pre-exposure prophylaxis effectiveness. Thus, non-HIV infections are as important to understanding susceptibility to HIV infection, its progression, and the effectiveness of treatments and prevention. Addressing these non-HIV predispository infections may provide novel preventative, diagnostic, and therapeutic opportunities.https://www.academia.edu/122717237/Coinfections_increase_the_risk_of_HIV_acquisition_AIDS_progression_and_therapy_and_prophylaxis_failure_a_review
spellingShingle Robert Root-Bernstein
Coinfections increase the risk of HIV acquisition, AIDS progression, and therapy and prophylaxis failure: a review
Academia Medicine
title Coinfections increase the risk of HIV acquisition, AIDS progression, and therapy and prophylaxis failure: a review
title_full Coinfections increase the risk of HIV acquisition, AIDS progression, and therapy and prophylaxis failure: a review
title_fullStr Coinfections increase the risk of HIV acquisition, AIDS progression, and therapy and prophylaxis failure: a review
title_full_unstemmed Coinfections increase the risk of HIV acquisition, AIDS progression, and therapy and prophylaxis failure: a review
title_short Coinfections increase the risk of HIV acquisition, AIDS progression, and therapy and prophylaxis failure: a review
title_sort coinfections increase the risk of hiv acquisition aids progression and therapy and prophylaxis failure a review
url https://www.academia.edu/122717237/Coinfections_increase_the_risk_of_HIV_acquisition_AIDS_progression_and_therapy_and_prophylaxis_failure_a_review
work_keys_str_mv AT robertrootbernstein coinfectionsincreasetheriskofhivacquisitionaidsprogressionandtherapyandprophylaxisfailureareview